肿瘤突变-话题@MedSci

#肿瘤突变#

19篇内容 | 719人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1654209, encodeId=edb7165420950, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Nature Cancer观点 | 肿瘤突变负荷与免疫治疗的现状, objectType=article, longId=734642, objectId=cff3e34642ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cff3e34642ed, replyNumber=0, likeNumber=30, createdTime=2022-11-29, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff3e34642ed, moduleTitle=Nature Cancer观点 | 肿瘤突变负荷与免疫治疗的现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cff3e34642ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654208, encodeId=90fc1654208d6, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Nature Cancer观点：肿瘤突变负荷与免疫治疗的现状, objectType=article, longId=733992, objectId=5264e3399282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5264e3399282, replyNumber=0, likeNumber=43, createdTime=2022-08-21, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5264e3399282, moduleTitle=Nature Cancer观点：肿瘤突变负荷与免疫治疗的现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5264e3399282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654207, encodeId=ca5a165420eae, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Nat Med：血源性肿瘤突变负担作为非小细胞肺癌阿特珠单抗治疗的生物标志物, objectType=article, longId=724549, objectId=b40de24549be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40de24549be, replyNumber=0, likeNumber=38, createdTime=2023-03-29, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40de24549be, moduleTitle=Nat Med：血源性肿瘤突变负担作为非小细胞肺癌阿特珠单抗治疗的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40de24549be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654206, encodeId=c0f9165420667, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=AACR重磅：高基因扩增和肿瘤突变负荷组合作为接受替雷丽珠单抗治疗患者的泛癌生物标志物, objectType=article, longId=723965, objectId=ef58e23965b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef58e23965b0, replyNumber=0, likeNumber=31, createdTime=2023-01-31, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef58e23965b0, moduleTitle=AACR重磅：高基因扩增和肿瘤突变负荷组合作为接受替雷丽珠单抗治疗患者的泛癌生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef58e23965b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654205, encodeId=e23e1654205f9, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究, objectType=article, longId=723964, objectId=100be239645b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=100be239645b, replyNumber=0, likeNumber=50, createdTime=2022-08-08, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=100be239645b, moduleTitle=AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=100be239645b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654203, encodeId=76e416542038e, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Cancer Immunol Immunother：肿瘤突变评分(TMS)取代肿瘤突变负荷(TMB)预测NSCLC患者对ICI治疗的反应性？, objectType=article, longId=206834, objectId=5369206834ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5369206834ca, replyNumber=0, likeNumber=38, createdTime=2021-04-24, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5369206834ca, moduleTitle=Cancer Immunol Immunother：肿瘤突变评分(TMS)取代肿瘤突变负荷(TMB)预测NSCLC患者对ICI治疗的反应性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5369206834ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654204, encodeId=d8881654204b6, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后, objectType=article, longId=212770, objectId=6d66212e701d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d66212e701d, replyNumber=0, likeNumber=34, createdTime=2021-07-10, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d66212e701d, moduleTitle=ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d66212e701d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654202, encodeId=8be816542029d, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Clin Cancer Res：根据ctDNA量化的肿瘤突变负荷可很好的预测转移性NSCLC患者是否能从免疫治疗中获益, objectType=article, longId=206791, objectId=9e27206e91ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e27206e91ca, replyNumber=0, likeNumber=33, createdTime=2021-04-28, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e27206e91ca, moduleTitle=Clin Cancer Res：根据ctDNA量化的肿瘤突变负荷可很好的预测转移性NSCLC患者是否能从免疫治疗中获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e27206e91ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654201, encodeId=38171654201f3, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Blood：单细胞测序揭示骨髓肿瘤突变上位性的遗传分子基础, objectType=article, longId=197688, objectId=b49119e688ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b49119e688ce, replyNumber=0, likeNumber=23, createdTime=2021-02-07, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b49119e688ce, moduleTitle=Blood：单细胞测序揭示骨髓肿瘤突变上位性的遗传分子基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b49119e688ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654200, encodeId=18ea165420087, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=CLIN CHEM LAB MED：使用液体活组织检查进行肿瘤突变定量的下一代测序, objectType=article, longId=190217, objectId=a95419021eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a95419021eb8, replyNumber=0, likeNumber=40, createdTime=2020-04-20, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a95419021eb8, moduleTitle=CLIN CHEM LAB MED：使用液体活组织检查进行肿瘤突变定量的下一代测序, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a95419021eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654198, encodeId=fe3e1654198ce, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Lancet Oncol：肿瘤突变负荷联合IFNγ基因表达特征可预测靶向治疗的III期黑色素瘤患者的预后, objectType=article, longId=187354, objectId=313c18e3543f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313c18e3543f, replyNumber=0, likeNumber=38, createdTime=2020-03-10, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313c18e3543f, moduleTitle=Lancet Oncol：肿瘤突变负荷联合IFNγ基因表达特征可预测靶向治疗的III期黑色素瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=313c18e3543f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654197, encodeId=98cf165419e8a, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=肿瘤突变评分预测免疫治疗预后可能优于TMB, objectType=article, longId=184140, objectId=1d0818414097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0818414097, replyNumber=0, likeNumber=34, createdTime=2020-09-16, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0818414097, moduleTitle=肿瘤突变评分预测免疫治疗预后可能优于TMB, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0818414097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654199, encodeId=c6eb165419930, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=2600多个基因组！Nature发布迄今全面癌症基因图谱，有望提前数十年识别出肿瘤突变, objectType=article, longId=187932, objectId=296418e93225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=296418e93225, replyNumber=0, likeNumber=41, createdTime=2020-09-03, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=296418e93225, moduleTitle=2600多个基因组！Nature发布迄今全面癌症基因图谱，有望提前数十年识别出肿瘤突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=296418e93225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654196, encodeId=622c165419665, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=JAMA：非小细胞肺癌患者肿瘤突变特征与预后, objectType=article, longId=164014, objectId=89d116401491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89d116401491, replyNumber=0, likeNumber=35, createdTime=2019-06-06, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89d116401491, moduleTitle=JAMA：非小细胞肺癌患者肿瘤突变特征与预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89d116401491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654195, encodeId=f2be165419553, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=JAMA Oncology：MUC16突变与更高的肿瘤突变量和更好的胃癌生存相关, objectType=article, longId=147011, objectId=e83914e01146, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e83914e01146, replyNumber=0, likeNumber=37, createdTime=2018-08-29, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e83914e01146, moduleTitle=JAMA Oncology：MUC16突变与更高的肿瘤突变量和更好的胃癌生存相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e83914e01146)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654194, encodeId=134d16541941e, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=Nature：肿瘤突变靶向药物的疗效受突变类型及肿瘤组织环境影响！, objectType=article, longId=129374, objectId=507f1293e416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507f1293e416, replyNumber=0, likeNumber=35, createdTime=2018-06-21, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507f1293e416, moduleTitle=Nature：肿瘤突变靶向药物的疗效受突变类型及肿瘤组织环境影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507f1293e416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654193, encodeId=aa2e165419360, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用, objectType=article, longId=116642, objectId=d179116642cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d179116642cc, replyNumber=0, likeNumber=34, createdTime=2018-07-24, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d179116642cc, moduleTitle=[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d179116642cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654192, encodeId=8703165419214, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=N Engl J Med：肿瘤突变负荷能为纳武单抗一线治疗晚期NSCLC争取一席之地吗, objectType=article, longId=103880, objectId=d0ce1038808e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0ce1038808e, replyNumber=0, likeNumber=0, createdTime=2017-10-14, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0ce1038808e, moduleTitle=N Engl J Med：肿瘤突变负荷能为纳武单抗一线治疗晚期NSCLC争取一席之地吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0ce1038808e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1654191, encodeId=5d49165419149, content=<a href='/topic/show?id=bd8083046d5' target=_blank style='color:#2F92EE;'>#肿瘤突变#</a>, objectTitle=AJRCCM：利用唾液也能检测肿瘤突变？, objectType=article, longId=42775, objectId=7e4742e75bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4742e75bd, replyNumber=0, likeNumber=37, createdTime=2015-07-10, rootId=0, userName=zhlpower, userId=52c424471043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4742e75bd, moduleTitle=AJRCCM：利用唾液也能检测肿瘤突变？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4742e75bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤突变

2020-05-29

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Nature Cancer观点 | 肿瘤突变负荷与免疫治疗的现状

2022-11-29

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Nature Cancer观点：肿瘤突变负荷与免疫治疗的现状

2022-08-21

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Nat Med：血源性肿瘤突变负担作为非小细胞肺癌阿特珠单抗治疗的生物标志物

2023-03-29

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

AACR重磅：高基因扩增和肿瘤突变负荷组合作为接受替雷丽珠单抗治疗患者的泛癌生物标志物

2023-01-31

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究

2022-08-08

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Cancer Immunol Immunother：肿瘤突变评分(TMS)取代肿瘤突变负荷(TMB)预测NSCLC患者对ICI治疗的反应性？

2021-04-24

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

ESMO Open：肿瘤突变负荷可预测口腔鳞状细胞癌患者预后

2021-07-10

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Clin Cancer Res：根据ctDNA量化的肿瘤突变负荷可很好的预测转移性NSCLC患者是否能从免疫治疗中获益

2021-04-28

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Blood：单细胞测序揭示骨髓肿瘤突变上位性的遗传分子基础

2021-02-07

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

CLIN CHEM LAB MED：使用液体活组织检查进行肿瘤突变定量的下一代测序

2020-04-20

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Lancet Oncol：肿瘤突变负荷联合IFNγ基因表达特征可预测靶向治疗的III期黑色素瘤患者的预后

2020-03-10

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

肿瘤突变评分预测免疫治疗预后可能优于TMB

2020-09-16

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

2600多个基因组！Nature发布迄今全面癌症基因图谱，有望提前数十年识别出肿瘤突变

2020-09-03

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

JAMA：非小细胞肺癌患者肿瘤突变特征与预后

2019-06-06

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

JAMA Oncology：MUC16突变与更高的肿瘤突变量和更好的胃癌生存相关

2018-08-29

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

Nature：肿瘤突变靶向药物的疗效受突变类型及肿瘤组织环境影响！

2018-06-21

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

[WCLC2017]胡洁教授深入解读ctDNA检测肿瘤突变负荷（TMB）在中国肺癌免疫治疗中的应用

2018-07-24

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

N Engl J Med：肿瘤突变负荷能为纳武单抗一线治疗晚期NSCLC争取一席之地吗

2017-10-14

zhlpower (审核中...)

前往app查看评论内容

#肿瘤突变#

AJRCCM：利用唾液也能检测肿瘤突变？

2015-07-10

科室
- - 订阅+
  - 更多科室
工具
服务